NCT03323671View on ClinicalTrials.gov

Preemptive Analgesia for Primary Dysmenorrhoea

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions
Primary Dysmenorrhea
Interventions
DRUG

preemptive mefenamic acid

preemptive analgesia before menstrual pain

DRUG

mefenamic acid

mefenamic acid given only during menstruation

Trial Locations (1)

35516

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Hanan Nabil

OTHER

NCT03323671 - Preemptive Analgesia for Primary Dysmenorrhoea | Biotech Hunter | Biotech Hunter